Filing Flows › Integrated Biopharma (INBP) › Net income
Integrated Biopharma (INBP) net income by quarter
Integrated Biopharma's net income was $123K in Q1 FY26 (first quarter fiscal 2026), -80% from Q3 FY25. Over the last 3 quarters it ranged from $116K (Q2 FY25) to $611K (Q3 FY25).
| Quarter | Net income | Q/Q | Y/Y |
|---|---|---|---|
| Q1 FY26 | $123K | -80% | — |
| Q3 FY25 | $611K | +427% | — |
| Q2 FY25 | $116K | — | — |
Q1 FY26 at a glance
Integrated Biopharma, Q1 FY26: revenue $12.7M (-7% year over year), operating margin 1.3%, net earnings $123K, operating cash flow $1.3M. The chart follows the revenue to costs, profit and cash.
Questions
What is Integrated Biopharma's net income?
Integrated Biopharma's net income was $123K in Q1 FY26 (first quarter fiscal 2026), -80% from Q3 FY25.
How has Integrated Biopharma's net income changed?
Over the last 3 quarters it ranged from $116K (Q2 FY25) to $611K (Q3 FY25).